| What about design newness? Investigating the relevance of a neglected dimension of product innovativeness K Talke, S Salomo, JE Wieringa, A Lutz Journal of product innovation management 26 (6), 601-615, 2009 | 287 | 2009 |
| Understanding customer switching behavior in a liberalizing service market: an exploratory study JE Wieringa, PC Verhoef Journal of Service Research 10 (2), 174-186, 2007 | 228 | 2007 |
| Why do firms invest in consumer advertising with limited sales response? A shareholder perspective EC Osinga, PSH Leeflang, S Srinivasan, JE Wieringa Journal of Marketing 75 (1), 109-124, 2011 | 159 | 2011 |
| Generalizations on the effectiveness of pharmaceutical promotional expenditures STM Kremer, THA Bijmolt, PSH Leeflang, JE Wieringa International Journal of Research in Marketing 25 (4), 234-246, 2008 | 143 | 2008 |
| Creating lift versus building the base: current trends in marketing dynamics PSH Leeflang, THA Bijmolt, J Van Doorn, DM Hanssens, HJ Van Heerde, ... International Journal of Research in Marketing 26 (1), 13-20, 2009 | 118 | 2009 |
| The role of marketing in digital business platforms A Rangaswamy, N Moch, C Felten, G Van Bruggen, JE Wieringa, J Wirtz Journal of Interactive Marketing 51, 72-90, 2020 | 111 | 2020 |
| Statistical process control for serially correlated data JE Wieringa Labyrint Publication, 1999 | 109 | 1999 |
| Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis PGM Mol, JE Wieringa, PV NannanPanday, ROB Gans, JE Degener, ... Journal of Antimicrobial Chemotherapy 55 (4), 550-557, 2005 | 102 | 2005 |
| Understanding firm, physician and consumer choice behavior in the pharmaceutical industry P Manchanda, DR Wittink, A Ching, P Cleanthous, M Ding, XJ Dong, ... Marketing Letters 16 (3), 293-308, 2005 | 96 | 2005 |
| Early marketing matters: A time-varying parameter approach to persistence modeling EC Osinga, PSH Leeflang, JE Wieringa Journal of Marketing Research 47 (1), 173-185, 2010 | 88 | 2010 |
| Data analytics in a privacy-concerned world J Wieringa, PK Kannan, X Ma, T Reutterer, H Risselada, B Skiera Journal of Business Research 122, 915-925, 2021 | 69 | 2021 |
| Visual outcome, treatment results, and prognostic factors in patients with scleritis WG Wieringa, JE Wieringa, H Ninette, LI Los Ophthalmology 120 (2), 379-386, 2013 | 64 | 2013 |
| Modeling markets P Leeflang, JE Wieringa, THA Bijmolt, KH Pauwels Springer-Verlag New York, 2016 | 62 | 2016 |
| Competitive reaction-and feedback effects based on VARX models of pooled store data C Horvath, PSH Leeflang, JE Wieringa, DR Wittink International Journal of Research in Marketing 22 (4), 415-426, 2005 | 57 | 2005 |
| Modeling the effects of pharmaceutical marketing PSH Leeflang, JE Wieringa Marketing Letters 21 (2), 121-133, 2010 | 52 | 2010 |
| No future without the past? Predicting churn in the face of customer privacy N Holtrop, JE Wieringa, MJ Gijsenberg, PC Verhoef International Journal of Research in Marketing 34 (1), 154-172, 2017 | 42 | 2017 |
| Advanced methods for modeling markets PSH Leeflang, JE Wieringa, THA Bijmolt, KH Pauwels Springer, 2017 | 34 | 2017 |
| When direct health‐care professional communications have an impact on inappropriate and unsafe use of medicines KC Reber, S Piening, JE Wieringa, SMJM Straus, JM Raine, PA de Graeff, ... Clinical Pharmacology & Therapeutics 93 (4), 360-365, 2013 | 34 | 2013 |
| Impact of safety‐related regulatory action on drug use in ambulatory care in the Netherlands S Piening, KC Reber, JE Wieringa, SMJM Straus, PA de Graeff, ... Clinical Pharmacology & Therapeutics 91 (5), 838-845, 2012 | 31 | 2012 |
| Marketing variables in macro-level diffusion models E Ruiz-Conde, PSH Leeflang, JE Wieringa Journal für Betriebswirtschaft 56 (3), 155-183, 2006 | 25 | 2006 |
Tammo BijmoltProfessor of Marketing Research, University of GroningenBestätigte E-Mail-Adresse bei rug.nl
